These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease. Liem RI; Lanzkron S; D Coates T; DeCastro L; Desai AA; Ataga KI; Cohen RT; Haynes J; Osunkwo I; Lebensburger JD; Lash JP; Wun T; Verhovsek M; Ontala E; Blaylark R; Alahdab F; Katabi A; Mustafa RA Blood Adv; 2019 Dec; 3(23):3867-3897. PubMed ID: 31794601 [TBL] [Abstract][Full Text] [Related]
3. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Brandow AM; Carroll CP; Creary S; Edwards-Elliott R; Glassberg J; Hurley RW; Kutlar A; Seisa M; Stinson J; Strouse JJ; Yusuf F; Zempsky W; Lang E Blood Adv; 2020 Jun; 4(12):2656-2701. PubMed ID: 32559294 [TBL] [Abstract][Full Text] [Related]
4. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Chou ST; Alsawas M; Fasano RM; Field JJ; Hendrickson JE; Howard J; Kameka M; Kwiatkowski JL; Pirenne F; Shi PA; Stowell SR; Thein SL; Westhoff CM; Wong TE; Akl EA Blood Adv; 2020 Jan; 4(2):327-355. PubMed ID: 31985807 [TBL] [Abstract][Full Text] [Related]
5. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. DeBaun MR; Jordan LC; King AA; Schatz J; Vichinsky E; Fox CK; McKinstry RC; Telfer P; Kraut MA; Daraz L; Kirkham FJ; Murad MH Blood Adv; 2020 Apr; 4(8):1554-1588. PubMed ID: 32298430 [TBL] [Abstract][Full Text] [Related]
6. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis. Cuker A; Tseng EK; Nieuwlaat R; Angchaisuksiri P; Blair C; Dane K; Davila J; DeSancho MT; Diuguid D; Griffin DO; Kahn SR; Klok FA; Lee AI; Neumann I; Pai A; Righini M; Sanfilippo KM; Siegal D; Skara M; Terrell DR; Touri K; Akl EA; Al Jabiri RN; Al Jabiri YN; Barbara AM; Bognanni A; Bou Akl I; Boulos M; Brignardello-Petersen R; Charide R; Chan M; Colunga-Lozano LE; Dearness K; Darzi AJ; Hussein H; Karam SG; Kolb P; Mansour R; Morgano GP; Morsi RZ; Muti-Schünemann G; Nadim MK; Noori A; Philip BA; Piggott T; Qiu Y; Benitez YR; Schünemann F; Stevens A; Solo K; Wiercioch W; Mustafa RA; Schünemann HJ Blood Adv; 2022 Jan; 6(2):664-671. PubMed ID: 34727173 [TBL] [Abstract][Full Text] [Related]
7. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Cuker A; Tseng EK; Nieuwlaat R; Angchaisuksiri P; Blair C; Dane K; Davila J; DeSancho MT; Diuguid D; Griffin DO; Kahn SR; Klok FA; Lee AI; Neumann I; Pai A; Righini M; Sanfilippo KM; Siegal D; Skara M; Terrell DR; Touri K; Akl EA; Bou Akl I; Bognanni A; Boulos M; Brignardello-Petersen R; Charide R; Chan M; Dearness K; Darzi AJ; Kolb P; Colunga-Lozano LE; Mansour R; Morgano GP; Morsi RZ; Muti-Schünemann G; Noori A; Philip BA; Piggott T; Qiu Y; Roldan Y; Schünemann F; Stevens A; Solo K; Wiercioch W; Mustafa RA; Schünemann HJ Blood Adv; 2021 Oct; 5(20):3951-3959. PubMed ID: 34474482 [TBL] [Abstract][Full Text] [Related]
8. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients. Cuker A; Tseng EK; Nieuwlaat R; Angchaisuksiri P; Blair C; Dane K; DeSancho MT; Diuguid D; Griffin DO; Kahn SR; Klok FA; Lee AI; Neumann I; Pai A; Righini M; Sanfilippo KM; Siegal DM; Skara M; Terrell DR; Touri K; Akl EA; Al Jabiri R; Al Jabiri Y; Barbara AM; Bognanni A; Boulos M; Brignardello-Petersen R; Charide R; Colunga-Lozano LE; Dearness K; Darzi AJ; Hussein H; Karam SG; Mansour R; Morgano GP; Morsi RZ; Muti-Schünemann G; Nadim MK; Philip BA; Qiu Y; Benitez YR; Stevens A; Solo K; Wiercioch W; Mustafa RA; Schünemann HJ Blood Adv; 2022 Sep; 6(17):4915-4923. PubMed ID: 35503027 [TBL] [Abstract][Full Text] [Related]
9. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Cuker A; Tseng EK; Nieuwlaat R; Angchaisuksiri P; Blair C; Dane K; Davila J; DeSancho MT; Diuguid D; Griffin DO; Kahn SR; Klok FA; Lee AI; Neumann I; Pai A; Pai M; Righini M; Sanfilippo KM; Siegal D; Skara M; Touri K; Akl EA; Bou Akl I; Boulos M; Brignardello-Petersen R; Charide R; Chan M; Dearness K; Darzi AJ; Kolb P; Colunga-Lozano LE; Mansour R; Morgano GP; Morsi RZ; Noori A; Piggott T; Qiu Y; Roldan Y; Schünemann F; Stevens A; Solo K; Ventresca M; Wiercioch W; Mustafa RA; Schünemann HJ Blood Adv; 2021 Feb; 5(3):872-888. PubMed ID: 33560401 [TBL] [Abstract][Full Text] [Related]
10. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients. Cuker A; Tseng EK; Schünemann HJ; Angchaisuksiri P; Blair C; Dane K; DeSancho MT; Diuguid D; Griffin DO; Kahn SR; Klok FA; Lee AI; Neumann I; Pai A; Righini M; Sanfilippo KM; Siegal DM; Skara M; Terrell DR; Touri K; Akl EA; Al Jabiri R; Al Jabiri Y; Boulos M; Brignardello-Petersen R; Charide R; Colunga-Lozano LE; Dearness K; Darzi AJ; Karam SG; Morgano GP; Morsi RZ; Philip BA; Benitez YR; Stevens A; Solo K; Wiercioch W; Mustafa RA; Nieuwlaat R Blood Adv; 2022 Sep; 6(17):4975-4982. PubMed ID: 35748885 [TBL] [Abstract][Full Text] [Related]
11. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Neunert C; Terrell DR; Arnold DM; Buchanan G; Cines DB; Cooper N; Cuker A; Despotovic JM; George JN; Grace RF; Kühne T; Kuter DJ; Lim W; McCrae KR; Pruitt B; Shimanek H; Vesely SK Blood Adv; 2019 Dec; 3(23):3829-3866. PubMed ID: 31794604 [TBL] [Abstract][Full Text] [Related]
12. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Connell NT; Flood VH; Brignardello-Petersen R; Abdul-Kadir R; Arapshian A; Couper S; Grow JM; Kouides P; Laffan M; Lavin M; Leebeek FWG; O'Brien SH; Ozelo MC; Tosetto A; Weyand AC; James PD; Kalot MA; Husainat N; Mustafa RA Blood Adv; 2021 Jan; 5(1):301-325. PubMed ID: 33570647 [TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist/oncologists' practice focus: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) study. Meier ER; Abraham AA; Ngwube A; Janson IA; Guilcher GMT; Horan J; Kasow KA Pediatr Blood Cancer; 2021 Mar; 68(3):e28861. PubMed ID: 33405370 [TBL] [Abstract][Full Text] [Related]
14. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Monagle P; Cuello CA; Augustine C; Bonduel M; Brandão LR; Capman T; Chan AKC; Hanson S; Male C; Meerpohl J; Newall F; O'Brien SH; Raffini L; van Ommen H; Wiernikowski J; Williams S; Bhatt M; Riva JJ; Roldan Y; Schwab N; Mustafa RA; Vesely SK Blood Adv; 2018 Nov; 2(22):3292-3316. PubMed ID: 30482766 [TBL] [Abstract][Full Text] [Related]
15. American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults. Sekeres MA; Guyatt G; Abel G; Alibhai S; Altman JK; Buckstein R; Choe H; Desai P; Erba H; Hourigan CS; LeBlanc TW; Litzow M; MacEachern J; Michaelis LC; Mukherjee S; O'Dwyer K; Rosko A; Stone R; Agarwal A; Colunga-Lozano LE; Chang Y; Hao Q; Brignardello-Petersen R Blood Adv; 2020 Aug; 4(15):3528-3549. PubMed ID: 32761235 [TBL] [Abstract][Full Text] [Related]
16. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. James PD; Connell NT; Ameer B; Di Paola J; Eikenboom J; Giraud N; Haberichter S; Jacobs-Pratt V; Konkle B; McLintock C; McRae S; R Montgomery R; O'Donnell JS; Scappe N; Sidonio R; Flood VH; Husainat N; Kalot MA; Mustafa RA Blood Adv; 2021 Jan; 5(1):280-300. PubMed ID: 33570651 [TBL] [Abstract][Full Text] [Related]
17. A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease. Rotin LE; Viswabandya A; Kumar R; Patriquin CJ; Kuo KHM Hematology; 2023 Dec; 28(1):2163357. PubMed ID: 36728286 [TBL] [Abstract][Full Text] [Related]
18. 2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations. Murad MH; Liem RI; Lang ES; Akl EA; Meerpohl JJ; DeBaun MR; Tisdale JF; Brandow AM; Lanzkron SM; Chou ST; Webb S; Mustafa RA Blood Adv; 2019 Dec; 3(23):3945-3950. PubMed ID: 31794603 [TBL] [Abstract][Full Text] [Related]
19. Stable renal function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation. Pedersen SJV; Monagel DA; Mammen C; Lewis VA; Guilcher GMT; Bruce AA Pediatr Blood Cancer; 2020 Sep; 67(9):e28568. PubMed ID: 32672896 [TBL] [Abstract][Full Text] [Related]
20. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]